Researchers follow varied molecular paths toward better control of organ rejection.
Goldsmith
M F
MF
D003524:Cyclosporins / Q000627:therapeutic use; D006084:Graft Rejection / Q000187:drug effects* / Q000276:immunology; D006537:Heptanoates / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012106:Research
D003524:Cyclosporins; D006537:Heptanoates; D007166:Immunosuppressive Agents; C020804:succinylacetone; D009173:Mycophenolic Acid